INSIGHTS ON CELL & GENE THERAPY LOGISTICS
-
Global Implications Of Zero Tariffs On Indian Pharma Exports To China
Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
Develop A Cost-Effective cGMP Chemical Sourcing Strategy
Outsourcing your cGMP chemical supply chain can significantly reduce capital and operating expenses, minimize production delays, and boost manufacturing productivity through improved sourcing and logistics.
-
Commercializing Your First CGT Product: Value Chain Planning
Effective value chain planning for cell and gene therapies requires early decisions on manufacturing, complex cold storage solutions, flexible reimbursement models, and scalable partnerships.
-
Are You Still Evaluating CMOs When You Really Need A CDMO?
Outsourcing adds capacity and specialized knowledge to your supply chain. But contractors come in several types. Here's how to pick the right one.
-
How Blast Freezing Affects The Quality Of Bottled Drug Substance: Test Results And Insights
Uneven ice formation during bottle freezing creates a "Volcano Effect," pushing solutes into highly concentrated zones. This test-based study explains this risk to drug substance quality.
-
Freezing Bottles – 5 Critical Considerations
Learn five critical considerations for freezing bottles, including uniform rate control, container integrity, and selecting the right freezing technology to maintain product stability and process efficiency.
-
New Guide Aims To Build Robust Framework For Digital Validation Tools
The ISPE's new guide addresses software for managing digital assets related to qualification, verification, validation, and compliance assurance.
-
Pfizer's Accord For A Healthier World Program Challenges Stability Study Norms
The company developed a novel approach to address the historic lack of stability testing for underserved parts of the world, near the equator.
-
Inside The Operational Hurdles Of Advanced Therapy Medicinal Products
Despite rapid approvals, ATMP patient access is limited by operational bottlenecks. Successfully delivering these therapies demands tightly synchronized logistics and resilient contingency planning.
-
100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing
Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.